tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Derik De Bruin, 22 are a SELL (16.92%), 54 are a HOLD (41.54%), 54 are a BUY (41.54%).
Analyst Derik De Bruin, carries an average stock price target met ratio of 72.36% that have a potential upside of 13.51% achieved within 115 days. Previously, Derik De Bruin worked at BAML.
Derik De Bruin’s has documented 262 price targets and ratings displayed on 34 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BRKR, Bruker at 15-Dec-2025.
Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/16/2022. The price target of $22.5 was fulfilled within 2 days with a profit of $3 (15.38%) receiving and performance score of 76.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jun-2016
$170
$52.33 (44.47%)
$185
15 days ago
(09-Feb-2026)
4/21 (19.05%)
$52.75 (44.99%)
94
Hold Since 10-Nov-2023
$150
$32.33 (27.48%)
$130
29 days ago
(26-Jan-2026)
11/26 (42.31%)
$-3 (-1.96%)
88
Buy Since 18-Jan-2022
$155
$37.33 (31.72%)
$135
1 months 4 days ago
(20-Jan-2026)
11/19 (57.89%)
$7.83 (5.32%)
140
Hold Since 31-Oct-2025
$130
$12.33 (10.48%)
$105
2 months 9 days ago
(15-Dec-2025)
1/2 (50%)
$-4.92 (-3.65%)
2
Hold Since 10-Aug-2023
$130
$12.33 (10.48%)
$100
2 months 9 days ago
(15-Dec-2025)
5/6 (83.33%)
$-4.92 (-3.65%)
26
Which stock is Derik De Bruin is most bullish on?
Which stock is Derik De Bruin is most reserved on?
What Year was the first public recommendation made by Derik De Bruin?
